Healthcare
Street Notes
By Emily Dattilo
Updated Oct 11, 2023, 9:36 am EDT / Original Oct 11, 2023, 7:44 am EDT
*pointer-events:none;.css-1ftbuf0-MainStack:has(:focus-visible)outline-color:rgba(54,119,168,1);outline-style:solid;outline-width:3px;outline-offset:1px;]]>*pointer-events:none;.css-ligzvc-MainStack:has(:focus-visible)outline-color:rgba(54,119,168,1);outline-style:solid;outline-width:3px;outline-offset:1px;]]>Share
Reprints
The chief executive’s retirement and a revenue warning from has turned one analyst team bearish on the medical devices company and sent the stock tumbling double-digits Wednesday.
Continue reading this article with a Barron’s subscription.
View Options
2023-10-11 08:36:00
Post from www.barrons.com
rnrn
Healthcare
Street Notes
By Emily Dattilo
Updated Oct 11, 2023, 9:36 am EDT / Original Oct 11, 2023, 7:44 am EDT
*pointer-events:none;.css-1ftbuf0-MainStack:has(:focus-visible)outline-color:rgba(54,119,168,1);outline-style:solid;outline-width:3px;outline-offset:1px;]]>*pointer-events:none;.css-ligzvc-MainStack:has(:focus-visible)outline-color:rgba(54,119,168,1);outline-style:solid;outline-width:3px;outline-offset:1px;]]>Share
Reprints
The chief executive’s retirement and a revenue warning from has turned one analyst team bearish on the medical devices company and sent the stock tumbling double-digits Wednesday.
Continue reading this article with a Barron’s subscription.
View Options
2023-10-11 08:36:00
Post from www.barrons.com
rnrn
